2024 Industry Outlook: ENT, Allergy, and Asthma Practices
Otolaryngology (“ENT”), allergy, and asthma (“ENTA&A”) related medical practices have been enjoying a robust period of investor interest as private-equity backed physician-practice management (“PPM”) companies and health systems have sought to align with providers in this sector. With opportunities for multiple ancillary offerings such as audiology and hearing aid sales, to the ability for ENT […]
2024 Industry Outlook: ENT, Allergy, and Asthma Practices Read More »